409 related articles for article (PubMed ID: 15897279)
1. Impaired early B cell tolerance in patients with rheumatoid arthritis.
Samuels J; Ng YS; Coupillaud C; Paget D; Meffre E
J Exp Med; 2005 May; 201(10):1659-67. PubMed ID: 15897279
[TBL] [Abstract][Full Text] [Related]
2. Human B cell tolerance and its failure in rheumatoid arthritis.
Samuels J; Ng YS; Coupillaud C; Paget D; Meffre E
Ann N Y Acad Sci; 2005 Dec; 1062():116-26. PubMed ID: 16461794
[TBL] [Abstract][Full Text] [Related]
3. B cells in rheumatoid arthritis.
Bugatti S; Codullo V; Caporali R; Montecucco C
Autoimmun Rev; 2007 Dec; 7(2):137-42. PubMed ID: 18035324
[TBL] [Abstract][Full Text] [Related]
4. Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice.
López-Hoyos M; Marquina R; Tamayo E; González-Rojas J; Izui S; Merino R; Merino J
Arthritis Rheum; 2003 Aug; 48(8):2353-61. PubMed ID: 12905491
[TBL] [Abstract][Full Text] [Related]
5. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
Hill JA; Al-Bishri J; Gladman DD; Cairns E; Bell DA
J Rheumatol; 2006 Nov; 33(11):2115-9. PubMed ID: 16924693
[TBL] [Abstract][Full Text] [Related]
6. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.
Verpoort KN; Jol-van der Zijde CM; Papendrecht-van der Voort EA; Ioan-Facsinay A; Drijfhout JW; van Tol MJ; Breedveld FC; Huizinga TW; Toes RE
Arthritis Rheum; 2006 Dec; 54(12):3799-808. PubMed ID: 17133560
[TBL] [Abstract][Full Text] [Related]
7. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
8. Limited VH gene usage in B-cell clones established with nurse-like cells from patients with rheumatoid arthritis.
Nakamura-Kikuoka S; Takahi K; Tsuboi H; Toyosaki-Maeda T; Maeda-Tanimura M; Wakasa C; Kikuchi N; Norioka S; Iwasaki M; Matsutani T; Itoh T; Yamane S; Takemoto H; Tsuruta Y; Shimaoka Y; Yukioka M; Suzuki R; Ochi T
Rheumatology (Oxford); 2006 May; 45(5):549-57. PubMed ID: 16368734
[TBL] [Abstract][Full Text] [Related]
9. B-cell tolerance checkpoints in health and autoimmunity.
Meffre E; Wardemann H
Curr Opin Immunol; 2008 Dec; 20(6):632-8. PubMed ID: 18848883
[TBL] [Abstract][Full Text] [Related]
10. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
11. B cells in rheumatoid arthritis.
Bugatti S; Codullo V; Caporali R; Montecucco C
Autoimmun Rev; 2007 Aug; 6(7):482-7. PubMed ID: 17643937
[TBL] [Abstract][Full Text] [Related]
12. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.
Meijer CJ; Cnossen J; Lafeber GJ; Damsteeg MJ; Cats A
Clin Exp Immunol; 1982 Feb; 47(2):368-80. PubMed ID: 6978781
[TBL] [Abstract][Full Text] [Related]
14. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
16. Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis.
Suzuki A; Yamada R; Ohtake-Yamanaka M; Okazaki Y; Sawada T; Yamamoto K
Biochem Biophys Res Commun; 2005 Jul; 333(2):418-26. PubMed ID: 15950180
[TBL] [Abstract][Full Text] [Related]
17. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
18. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
Dörner T
J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach.
Matsuo K; Xiang Y; Nakamura H; Masuko K; Yudoh K; Noyori K; Nishioka K; Saito T; Kato T
Arthritis Res Ther; 2006; 8(6):R175. PubMed ID: 17125526
[TBL] [Abstract][Full Text] [Related]
20. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
